EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieValidierungsstudieOpen Access · CC BY 4.0

Assessing the Concurrent Validity of the Australian Treatment Outcomes Profile in a Methamphetamine Dependent Treatment‐Seeking Population

Brendan Clifford iD, Rachel M Deacon, Kristie Mammen, Krista J Siefried, Nadine Ezard, Nicholas Lintzeris

Drug and Alcohol Review · 2026

DOI: 10.1111/dar.70224 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug and Alcohol Review, 2026. Verfasst von Brendan Clifford und 5 weiteren Autor:innen. Beteiligte Einrichtung: Alcohol and Drug Service, St Vincent's Hospital Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Amphetamine-Related Disorders, Methamphetamine. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, St Vincent's Inclusive Health Program, The Curran Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The Australian Treatment Outcomes Profile (ATOP) is a brief clinical tool assessing substance use, health and well‐being used in Australian alcohol and other drug treatment services. It is validated for use with clients using alcohol, opioids and cannabis, but not yet for clients who primarily use methamphetamine.

Methods

An embedded validation study was undertaken in treatment‐seeking adults enrolled in a randomised double‐blind placebo‐controlled trial of lisdexamfetamine for methamphetamine dependence with sites in New South Wales, South Australia and Victoria. Participant demographics were collected during study screening. The ATOP and comparators (Time Line Follow Back, Opiate Treatment Index, Depression Anxiety Stress Scale, WHOQOL‐BREF and Personal Wellbeing Index) were collected at baseline. Continuous ATOP items were analysed using Pearson's correlation coefficient, and dichotomous items were analysed using Fleiss's κ . Agreement was rated as strong where measures were ≥ 0.50, moderate where agreement was 0.30–0.49, and weak where < 0.30.

Results

One hundred and eighteen study participants (2018–2020) had data for concurrent validity analysis. Strong validity was demonstrated for physical health, psychological health, quality of life, injecting drug use and crime items, and for days of use for amphetamines, alcohol, cannabis and cocaine. There was weak validity for days of use for benzodiazepines. Heroin use days and other opioid use days were endorsed by fewer than five participants and were therefore unable to be assessed. Discussion and Conclusions The ATOP is valid for use in a treatment‐seeking methamphetamine‐dependent population, expanding the range of tools for assessment and standardised outcome monitoring across different settings and services.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphetamine-Related DisordersMethamphetamineHumansFemaleAdultMaleDouble-Blind MethodAustraliaTreatment OutcomeQuality of LifeReproducibility of ResultsMiddle Aged

Stichwörter der Autor:innen

amphetamine‐related disordersmethamphetamineoutcome assessmentpatient reported outcome measuressubstance use

Substanzen

Methamphetamine

Autor:innen und Institutionen

  • Alcohol and Drug Service, St Vincent's Hospital Sydney, Sydney, Australia.
  • National Centre for Clinical Research on Emerging Drugs, UNSW Sydney, Sydney, Australia.
  • New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN), Sydney, Australia.
  • National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
  • Specialty of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, Australia.

ORCID-Profile: Brendan Clifford

Förderung

  • National Health and Medical Research Council
  • St Vincent's Inclusive Health Program
  • The Curran Foundation

Zitieren

APA

Clifford, B., Deacon, R. M., Mammen, K., Siefried, K. J., Ezard, N., & Lintzeris, N. (2026). Assessing the Concurrent Validity of the Australian Treatment Outcomes Profile in a Methamphetamine Dependent Treatment‐Seeking Population. Drug and Alcohol Review. https://doi.org/10.1111/dar.70224

Vancouver

Clifford B, Deacon RM, Mammen K, Siefried KJ, Ezard N, Lintzeris N. Assessing the Concurrent Validity of the Australian Treatment Outcomes Profile in a Methamphetamine Dependent Treatment‐Seeking Population. Drug and Alcohol Review. 2026. doi:10.1111/dar.70224

BibTeX
@article{Clifford2026,
  author = {Clifford, Brendan and Deacon, Rachel M and Mammen, Kristie and Siefried, Krista J and Ezard, Nadine and Lintzeris, Nicholas},
  title = {Assessing the Concurrent Validity of the Australian Treatment Outcomes Profile in a Methamphetamine Dependent Treatment‐Seeking Population},
  journal = {Drug and Alcohol Review},
  year = {2026},
  doi = {10.1111/dar.70224}
}
Kostenlos starten →